SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-10
👔
Arcutis Biotherapeutics, Inc.
@ARQT_InsiderForm 4 Filing: Matsuda Masaru Sells $250K of $ARQT
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Arcutis Biotherapeutics, Inc.
Ticker: $ARQT
Transaction Value
$250K
Price/Share: $25.03
transaction date
2026-09-08
Shares: 9,989
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Matsuda Masaru, holds the title of See Remarks at Arcutis Biotherapeutics, Inc..
On 2026-09-08, the insider transacted 9,989 shares.The shares were transacted at a weighted average price of $25.03 per share, resulting in a total market-relevant value of $250K.
Executive Summary Summary
Matsuda Masaru (See Remarks) sold $250K of $ARQT
Post-Transaction Position: 116,182 shares
SEC Accession No: 0001628280-26-061444 (CIK: 1798679)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.